18th September 2019
Consilium Strategic Communications advises CMR Surgical on its £195 million ($240 million) Series C financing
London, 18 September 2019, Consilium Strategic Communications, a global leader in strategic healthcare communications and investor relations, is proud to have supported CMR Surgical, the company developing, manufacturing and marketing the next-generation surgical robotic system, Versius®, on the international communication of its £195 million ($240 million) fundraise.
The fundraise has been supported by existing investors: LGT, Escala Capital Investments, Cambridge Innovation Capital, Watrium, and Zhejiang Silk Road Fund as well as new US investors with deep sector knowledge. This financing is Europe’s largest private financing round in the medical technology sector and will fund the business through the planned global commercialisation of Versius® whilst supporting continued research and development, manufacturing and expansion.
“Consilium has provided strategic advice and international media management to CMR Surgical for approximately five years during which time we have enjoyed seeing the company rapidly grow and develop its game-changing surgical robot. This latest fundraise is testament to the huge potential and investment appeal of the Versius system. We would like to congratulate the team at CMR on this successful fundraise and we look forward to continuing to work with the company as they prepare for the imminent commercial launch of the Versius system.”
Mary-Jane ElliottManaging Partner of Consilium Strategic Communications
The Consilium team representing CMR Surgical on the financing was: Mary-Jane Elliott, Angela Gray, Lindsey Neville and Lizzie Seeley in Europe and Catherine London in US.
To view CMR Surgical’s announcement please visit https://cmrsurgical.com/
For more information, please contact:
Consilium Strategic Communications
Mary-Jane Elliott / Amber Fennell
Tel: +44(0)20 3709 5700
Follow us: @consiliumhc
About Consilium Strategic Communications
Consilium Strategic Communications is a global leader in financial and corporate communications and investor relations focused on the healthcare sector. Consilium's team, based in both Europe and US, provides strategic, long-term PR and IR advice to healthcare companies, Boards, senior decision makers and executives on critical communications programmes, international media management, transactions and healthcare stakeholder challenges. Consilium has established deep knowledge and expertise across all areas of the global healthcare sector through broad involvement in representing international clients spanning the Fortune 500, FTSE 100, FTSEurofirst 300 and FTSE 250, through to
discrete specialist reputation management projects. For more information please see www.consilium-comms.com
About CMR Surgical Limited
CMR Surgical is a British private limited company responsible for the development of the next-generation universal robotic system, Versius®, for minimal access surgery. The company received the European CE Mark in March 2019 for the Versius® Surgical Robotic System.
The vision behind CMR Surgical is to make minimal access surgery universally accessible and affordable, transforming the existing market for surgical robotics while also addressing the six million people who still undergo open surgery each year.
Global annual revenues for robotic-assisted minimal access surgery are presently approximately $4 billion and are anticipated to reach $20 billion by 2025.
CMR Surgical, formed in 2014, has its headquarters in Cambridge, United Kingdom and is backed by an international shareholder base of specialist and generalist investors.
The Company achieved the registration of its Quality Management System to ISO 13485:2016 by Underwriters Laboratories LLC® (UL), and the status as a UL Registered Firm, in September 2015.
For further information, please visit www.cmrsurgical.com